The most prevalent B-cell non-Hodgkin lymphoma is diffuse large B-cell lymphoma (DLBCL). Various prognostic factors were known, including the revised international prognostic index (R-IPI), MYC/BCL2 overexpression by IHC,...
Read MorePatients with IBS-D had significantly higher percentages of moderate to severe anxiety and depression and considerably lower HRQOL versus controls. For patients with irritable bowel syndrome with diarrhea (IBS-D), symptoms such...
Read More
A number of CD19-targeted medicines, such as chimeric antigen receptor T-cell therapy (CAR-T),...
Read More
For tailored therapy selection and result optimization in diffuse large B-cell lymphoma (DLBCL),...
Read More
Results from the MIRROR RCT trial, presented at the 2022 American Society of Nephrology’s Kidney...
Read More
Gout flares occurred in 18% of patients with comorbid gout who were hospitalized for COVID-19,...
Read More
IgG-based elimination diets using a novel diagnostic tool to guide therapy may be beneficial to...
Read More
For patients with gout, urate-lowering therapy (ULT) increases the risk of hospitalizations within...
Read More
Individuals with hypercholesterolemia who had higher levels of campesterol experienced...
Read More
Limited research has been done on outcomes after the return of secondary findings in large-scale...
Read More
Tafolecimab provided significant, durable decreases in low-density lipoprotein cholesterol (LDL-C)...
Read More
VICTORION-INCEPTION is a phase IIIb, randomized, parallel-group, open-label, multicenter, US-based...
Read More
The principal finding from a 4-year open-label extension study of inclisiran—a small interfering...
Read More
For patients with refractory/relapsed acute myeloid leukemia (AML), total therapy, as compared...
Read More
Compared with their White counterparts, gout is more prevalent in Black adults, according to the...
Read More
Compared with patients with gout who did not experience a cardiovascular (CV) event, those who did...
Read More
In a randomized-controlled trial, cognitive rehabilitation therapy (CRT) and mindfulness-based...
Read More
Discontinuing natalizumab during the first trimester of pregnancy increased relapse risk during...
Read More
Do disease-modifying therapies (DMTs) in everyday practice delay the progression of disease in...
Read More
New research suggests that not only is MS preceded by Epstein-Barr virus (EBV) infection, but it...
Read More
